What’s New in Osteoporosis and Fragility Fractures 2022
The recent JBJS Guest Editorial “What’s New in Osteoporosis and Fragility Fractures” provides an update on this important …
The recent JBJS Guest Editorial “What’s New in Osteoporosis and Fragility Fractures” provides an update on this important …
In our ongoing attempt to identify pharmacologic interventions that improve fracture healing, the sclerostin inhibitor romosozumab is a logical candidate, …
We have all come to realize that promising results from lab studies or preclinical trials in animal models do not …